Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C12H15N5O5.ClH |
Molecular Weight | 345.739 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 4 / 4 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
Cl.NC(=O)C1=CN([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)C3=C1C(N)=NC=N3
InChI
InChIKey=WTSGTUMQZSEZIW-CCUUNMJDSA-N
InChI=1S/C12H15N5O5.ClH/c13-9-6-4(10(14)21)1-17(11(6)16-3-15-9)12-8(20)7(19)5(2-18)22-12;/h1,3,5,7-8,12,18-20H,2H2,(H2,14,21)(H2,13,15,16);1H/t5-,7-,8-,12-;/m1./s1
Molecular Formula | C12H15N5O5 |
Molecular Weight | 309.278 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 4 / 4 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
Molecular Formula | ClH |
Molecular Weight | 36.461 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: CHEMBL2093867 Sources: https://www.ncbi.nlm.nih.gov/pubmed/3338987 |
11.0 µM [Ki] | ||
Target ID: Erk signaling pathway Sources: https://www.ncbi.nlm.nih.gov/pubmed/24434142 |
PubMed
Title | Date | PubMed |
---|---|---|
Sangivamycin, a nucleoside analogue, is a potent inhibitor of protein kinase C. | 1988 Feb 5 |
|
Inhibition of tumor angiogenesis by targeting endothelial surface ATP synthase with sangivamycin. | 2007 Nov |
|
Sangivamycin induces apoptosis by suppressing Erk signaling in primary effusion lymphoma cells. | 2014 Feb 7 |
Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 15:07:39 GMT 2023
by
admin
on
Sat Dec 16 15:07:39 GMT 2023
|
Record UNII |
B1NYI0L8FN
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Code | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C259
Created by
admin on Sat Dec 16 15:07:40 GMT 2023 , Edited by admin on Sat Dec 16 15:07:40 GMT 2023
|
||
|
NCI_THESAURUS |
C2089
Created by
admin on Sat Dec 16 15:07:40 GMT 2023 , Edited by admin on Sat Dec 16 15:07:40 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
DTXSID20417691
Created by
admin on Sat Dec 16 15:07:40 GMT 2023 , Edited by admin on Sat Dec 16 15:07:40 GMT 2023
|
PRIMARY | |||
|
143648
Created by
admin on Sat Dec 16 15:07:40 GMT 2023 , Edited by admin on Sat Dec 16 15:07:40 GMT 2023
|
PRIMARY | |||
|
21159376
Created by
admin on Sat Dec 16 15:07:40 GMT 2023 , Edited by admin on Sat Dec 16 15:07:40 GMT 2023
|
PRIMARY | |||
|
C29417
Created by
admin on Sat Dec 16 15:07:40 GMT 2023 , Edited by admin on Sat Dec 16 15:07:40 GMT 2023
|
PRIMARY | NCIT | ||
|
21090-35-7
Created by
admin on Sat Dec 16 15:07:40 GMT 2023 , Edited by admin on Sat Dec 16 15:07:40 GMT 2023
|
PRIMARY | |||
|
B1NYI0L8FN
Created by
admin on Sat Dec 16 15:07:40 GMT 2023 , Edited by admin on Sat Dec 16 15:07:40 GMT 2023
|
PRIMARY | |||
|
1405-48-7
Created by
admin on Sat Dec 16 15:07:40 GMT 2023 , Edited by admin on Sat Dec 16 15:07:40 GMT 2023
|
SUPERSEDED |
Related Record | Type | Details | ||
---|---|---|---|---|
|
PARENT -> SALT/SOLVATE |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |